Related Experiment Video
Updated: Apr 27, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
The Cohort for Childhood Origin of Asthma and allergic diseases (COCOA) study: design, rationale and methods
Hyeon-Jong Yang, So-Yeon Lee, Dong In Suh
1Department of Pediatrics, Childhood Asthma Atopy Center, Research Center for Standardization of Allergic Diseases, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, 760, Korea. jooshil@korea.kr.
Insights
The COhort for Childhood Origin of Asthma and allergic diseases (COCOA) study investigates how genetics and environment impact childhood allergies. Understanding these factors and their interactions is key to preventing pediatric allergic diseases.
Area of Science:
- Environmental Health
- Pediatrics
- Genetics and Epigenetics
Background:
- Prospective birth-cohort study in Korea (COCOA) focusing on pediatric allergic diseases.
- Investigates the influence of genetics, perinatal environment, maternal lifestyle, and psychosocial stress.
Purpose of the Study:
- To determine individual and interactive effects of various factors on susceptibility to pediatric allergic diseases.
- To explore the causal contribution of environmental variables to the development and course of allergic diseases.
- To understand how genetics, epigenetics, and early-life exposures interact to shape allergic disease phenotypes.
Main Methods:
- Recruitment of mother-baby pairs from Seoul, Korea, from 2007-2015.
- Follow-up assessments from before birth to adolescence, including questionnaires and biological sample collection.
- Measurement of indoor/outdoor pollutants, maternal stress, nutrition, microbiome, child's genes, and epigenetics.
Main Results:
- The study design allows for comprehensive data collection on a wide range of potential risk factors.
- Analysis will focus on identifying key genetic and environmental contributors to allergic diseases.
- The interactive effects of these factors will be a primary focus of the investigation.
Conclusions:
- The COCOA study aims to enhance understanding of genetic and environmental risk factors for allergic diseases.
- It will elucidate the complex interplay between these factors in shaping allergic disease phenotypes.
- Findings will contribute to improved prevention and management strategies for pediatric allergies.
Background:
This paper describes the background, aim, and design of a prospective birth-cohort study in Korea called the COhort for Childhood Origin of Asthma and allergic diseases (COCOA). COCOA objectives are to investigate the individual and interactive effects of genetics, perinatal environment, maternal lifestyle, and psychosocial stress of mother and child on pediatric susceptibility to allergic diseases.
Methods/Design:
The participants in COCOA represents a Korean inner-city population. Recruitment started on 19 November, 2007 and will continue until 31 December, 2015. Recruitment is performed at five medical centers and eight public-health centers for antenatal care located in Seoul. Participating mother-baby pairs are followed from before birth to adolescents. COCOA investigates whether the following five environmental variables contribute causally to the development and natural course of allergic diseases: (1) perinatal indoor factors (i.e. house-dust mite, bacterial endotoxin, tobacco smoking, and particulate matters 2.5 and 10), (2) perinatal outdoor pollutants, (3) maternal prenatal psychosocial stress and the child's neurodevelopment, (4) perinatal nutrition, and (5) perinatal microbiome. Cord blood and blood samples from the child are used to assess whether the child's genes and epigenetic changes influence allergic-disease susceptibility. Thus, COCOA aims to investigate the contributions of genetics, epigenetics, and various environmental factors in early life to allergic-disease susceptibility in later life. How these variables interact to shape allergic-disease susceptibility is also a key aim.The COCOA data collection schedule includes 11 routine standardized follow-up assessments of all children at 6 months and every year until 10 years of age, regardless of allergic-disease development. The mothers will complete multiple questionnaires to assess the baseline characteristics, the child's exposure to environmental factors, maternal pre- and post-natal psychological stress, and the child's neurodevelopment, nutritional status, and development of allergic and respiratory illnesses. The child's microbiome, genes, epigenetics, plasma cytokine levels, and neuropsychological status, the microbiome of the residence, and the levels of indoor and outdoor pollutants are measured by standard procedures.
Discussion:
The COCOA study will improve our understanding of how individual genetic or environmental risk factors influence susceptibility to allergic disease and how these variables interact to shape the phenotype of allergic diseases.
More Related Videos
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma I: Introduction
Asthma III: Clinical Manifestations
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction